Martin Gleave
Martin Gleave
Professor of Urologic Sciences, University of British Columbia
Verified email at - Homepage
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
JA Locke, ES Guns, AA Lubik, HH Adomat, SC Hendy, CA Wood, ...
Cancer research 68 (15), 6407-6415, 2008
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ...
Cancer discovery 1 (6), 487-495, 2011
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development
M Gironella, M Seux, MJ Xie, C Cano, R Tomasini, J Gommeaux, S Garcia, ...
Proceedings of the National Academy of Sciences 104 (41), 16170-16175, 2007
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ...
The EMBO journal 30 (13), 2719-2733, 2011
Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells
HC Wu, JT Hsieh, ME Gleave, NM Brown, S Pathak, LWK Chung
International journal of cancer 57 (3), 406-412, 1994
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer
EA Mostaghel, ST Page, DW Lin, L Fazli, IM Coleman, LD True, ...
Cancer research 67 (10), 5033-5041, 2007
Acceleration of Human Prostate Cancer Growth in Vivo by Factors Produced by Prostate and Bone Fibroblasts
M Gleave, JT Hsieh, C Gao, AC Von Eschenbach, LWK Chung
Cancer research 51 (14), 3753-3761, 1991
Active surveillance of small renal masses: progression patterns of early stage kidney cancer
MAS Jewett, K Mattar, J Basiuk, CG Morash, SE Pautler, DR Siemens, ...
European urology 60 (1), 39-44, 2011
Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor CellsPten Loss and RAS Activation Cooperate to Promote …
DJ Mulholland, N Kobayashi, M Ruscetti, A Zhi, LM Tran, J Huang, ...
Cancer research 72 (7), 1878-1889, 2012
Genomic hallmarks and structural variation in metastatic prostate cancer
DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ...
Cell 174 (3), 758-769. e9, 2018
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate CancerAR Gene Aberrations in Circulating …
AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ...
Clinical cancer research 21 (10), 2315-2324, 2015
Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study
R Aggarwal, J Huang, JJ Alumkal, L Zhang, FY Feng, GV Thomas, ...
Journal of Clinical Oncology 36 (24), 2492, 2018
Antisense therapy for cancer
ME Gleave, BP Monia
Nature Reviews Cancer 5 (6), 468-479, 2005
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation
G Leprivier, M Remke, B Rotblat, A Dubuc, ARF Mateo, M Kool, ...
Cell 153 (5), 1064-1079, 2013
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer
P Rocchi, A So, S Kojima, M Signaevsky, E Beraldi, L Fazli, ...
Cancer research 64 (18), 6595-6602, 2004
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report
SL Goldenberg, N Bruchovsky, ME Gleave, LD Sullivan, K Akakura
Urology 45 (5), 839-845, 1995
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma
ME Gleave, M Elhilali, Y Fradet, I Davis, P Venner, F Saad, LH Klotz, ...
New England journal of medicine 338 (18), 1265-1271, 1998
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ...
Annals of Oncology 26 (8), 1589-1604, 2015
The system can't perform the operation now. Try again later.
Articles 1–20